STTCOMP TLX TA LONG
Telix Pharma
Market cap - around $1.4B
Oncology biotech with quite an extensive pipeline of products under development in renal, brain, prostate and other cancers. Aiming for FDA approval in around September. Very impressive management. Has been hitting resistance around 4.70/$4.80 but broke through convincingly on Friday. Not so confident about getting 25% in 4 weeks, given the size of the company, but that breakout was impressive.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 15 June
Short Term Trading Week Starting: 15 June, page-4
Featured News
Featured News
The Watchlist
AGC
AUSTRALIAN GOLD AND COPPER LTD
Glen Diemar, MD
Glen Diemar
MD
SPONSORED BY The Market Online